Cargando…

Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?

Due to the growing number of young patients at risk of germ cell loss, there is a need to preserve spermatogonial stem cells for patients who are not able to bank spermatozoa. Worldwide, more and more clinics are implementing testicular tissue (TT) banking programs, making it a novel, yet indispensa...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgouffe, Emily, Braye, Aude, Goossens, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960265/
https://www.ncbi.nlm.nih.gov/pubmed/35360062
http://dx.doi.org/10.3389/fendo.2022.854186
_version_ 1784677353748692992
author Delgouffe, Emily
Braye, Aude
Goossens, Ellen
author_facet Delgouffe, Emily
Braye, Aude
Goossens, Ellen
author_sort Delgouffe, Emily
collection PubMed
description Due to the growing number of young patients at risk of germ cell loss, there is a need to preserve spermatogonial stem cells for patients who are not able to bank spermatozoa. Worldwide, more and more clinics are implementing testicular tissue (TT) banking programs, making it a novel, yet indispensable, discipline in the field of fertility preservation. Previously, TT cryopreservation was predominantly offered to young cancer patients before starting gonadotoxic chemo- or radiotherapy. Nowadays, most centers also bank TT from patients with non-malignant conditions who need gonadotoxic conditioning therapy prior to hematopoietic stem cell (HSCT) or bone marrow transplantation (BMT). Additionally, some centers include patients who suffer from genetic or developmental disorders associated with prepubertal germ cell loss or patients who already had a previous round of chemo- or radiotherapy. It is important to note that the surgical removal of TT is an invasive procedure. Moreover, TT cryopreservation is still considered experimental as restoration methods are not yet clinically available. For this reason, TT banking should preferably only be offered to patients who are at significant risk of becoming infertile. In our view, TT cryopreservation is recommended for young cancer patients in need of high-risk chemo- and/or radiotherapy, regardless of previous low-risk treatment. Likewise, TT banking is advised for patients with non-malignant disorders such as sickle cell disease, beta-thalassemia, and bone marrow failure, who need high-risk conditioning therapy before HSCT/BMT. TT retrieval during orchidopexy is also proposed for patients with bilateral cryptorchidism. Since patients with a medium- to low-risk treatment generally maintain their fertility, TT banking is not advised for this group. Also for Klinefelter patients, TT banking is not recommended as it does not give better outcomes than a testicular sperm extraction later in life.
format Online
Article
Text
id pubmed-8960265
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89602652022-03-30 Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included? Delgouffe, Emily Braye, Aude Goossens, Ellen Front Endocrinol (Lausanne) Endocrinology Due to the growing number of young patients at risk of germ cell loss, there is a need to preserve spermatogonial stem cells for patients who are not able to bank spermatozoa. Worldwide, more and more clinics are implementing testicular tissue (TT) banking programs, making it a novel, yet indispensable, discipline in the field of fertility preservation. Previously, TT cryopreservation was predominantly offered to young cancer patients before starting gonadotoxic chemo- or radiotherapy. Nowadays, most centers also bank TT from patients with non-malignant conditions who need gonadotoxic conditioning therapy prior to hematopoietic stem cell (HSCT) or bone marrow transplantation (BMT). Additionally, some centers include patients who suffer from genetic or developmental disorders associated with prepubertal germ cell loss or patients who already had a previous round of chemo- or radiotherapy. It is important to note that the surgical removal of TT is an invasive procedure. Moreover, TT cryopreservation is still considered experimental as restoration methods are not yet clinically available. For this reason, TT banking should preferably only be offered to patients who are at significant risk of becoming infertile. In our view, TT cryopreservation is recommended for young cancer patients in need of high-risk chemo- and/or radiotherapy, regardless of previous low-risk treatment. Likewise, TT banking is advised for patients with non-malignant disorders such as sickle cell disease, beta-thalassemia, and bone marrow failure, who need high-risk conditioning therapy before HSCT/BMT. TT retrieval during orchidopexy is also proposed for patients with bilateral cryptorchidism. Since patients with a medium- to low-risk treatment generally maintain their fertility, TT banking is not advised for this group. Also for Klinefelter patients, TT banking is not recommended as it does not give better outcomes than a testicular sperm extraction later in life. Frontiers Media S.A. 2022-03-10 /pmc/articles/PMC8960265/ /pubmed/35360062 http://dx.doi.org/10.3389/fendo.2022.854186 Text en Copyright © 2022 Delgouffe, Braye and Goossens https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Delgouffe, Emily
Braye, Aude
Goossens, Ellen
Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title_full Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title_fullStr Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title_full_unstemmed Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title_short Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
title_sort testicular tissue banking for fertility preservation in young boys: which patients should be included?
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960265/
https://www.ncbi.nlm.nih.gov/pubmed/35360062
http://dx.doi.org/10.3389/fendo.2022.854186
work_keys_str_mv AT delgouffeemily testiculartissuebankingforfertilitypreservationinyoungboyswhichpatientsshouldbeincluded
AT brayeaude testiculartissuebankingforfertilitypreservationinyoungboyswhichpatientsshouldbeincluded
AT goossensellen testiculartissuebankingforfertilitypreservationinyoungboyswhichpatientsshouldbeincluded